Mandol and Gait deviation - a phase IV clinical study of FDA data
Summary:
We study 435 people who take Mandol (cefamandole nafate) or have Gait deviation. No report of Gait deviation is found in people who take Mandol.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
What is Mandol?
Mandol has active ingredients of cefamandole nafate. eHealthMe is studying from 299 Mandol users. Check the latest studies of Mandol.
What is Gait Deviation?
Gait deviation is found to be associated with 8 drugs and 153 conditions by eHealthMe. Check the latest studies of Gait deviation.
No report is found.
Do you take Mandol and have Gait deviation?
- Check whether Gait deviation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Mandol:
- Mandol (299 reports)
Gait deviation treatments and more:
- Gait deviation (136 reports)
How severe was Gait deviation and when was it recovered:
Expand to all the drugs that have ingredients of cefamandole nafate:
Browse all side effects of Mandol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Gait deviation:
Browse all the conditions that are associated with Gait deviation:
How the study uses the data?
The study uses data from the FDA. It is based on cefamandole nafate (the active ingredients of Mandol) and Mandol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Spiriva Respimat and Fioricet - 3 seconds ago
- Ear Pain and drugs of ingredients of lactobacillus - 15 seconds ago
- Lipitor and Blood Alkaline Phosphatase Increased for Men aged 50-59 - 17 seconds ago
- Tooth Loss and drugs of ingredients of human immunoglobulin g - 24 seconds ago
- Oxycodone and Dry Mouth for Women aged 40-49 - 28 seconds ago
- Keppra and Intrahepatic Cholestasis for Women aged 50-59 - 39 seconds ago
- Keppra and Extrahepatic Cholestasis for Women aged 50-59 - 39 seconds ago
- Keppra and Cholestasis for Women aged 50-59 - 39 seconds ago
- Could Micafungin Sodium cause Cytomegalovirus Infection? - 51 seconds ago
- Jevtana and Pepcid drug interactions for men aged 60+ - 57 seconds ago